🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This research study is testing whether a weekly medication called tirzepati...
Status
Recruiting
Location
Institut de Recherches Cliniques de Montréal
Start Date
2026-05-19
Trial ID
NCT07284511
The purpose of this study is to examine the pre, post, and follow up effect...
Status
Completed
Location
Reno Orthopedic Center
Start Date
2020-11-30
Trial ID
NCT05058209
This is a randomized, double-blind, placebo-controlled, parallel-group stud...
Status
Active Not Recruiting
Location
Shanghai Dermatology Hospital
Start Date
2024-09-23
Trial ID
NCT06554847
Treatments Being Tested
The purpose of this study is to investigate the safety and activity in the ...
Status
Completed
Location
Arensia Clinical Research Unit
Start Date
2019-08-14
Trial ID
NCT04073498
This study will evaluate the pharmacokinetics (area under the curve \[AUC\]...
Status
Completed
Location
Multiple Locations
Start Date
2004-02
Trial ID
NCT02864199
Treatments Being Tested
The aim of the TRICIDIA2 study is to compare two modalities of administrati...
Status
Unknown
Location
CHU
Start Date
2012-01
Trial ID
NCT01889914
Treatments Being Tested
This single arm study will assess the efficacy and safety of subcutaneous M...
Status
Terminated
Location
Multiple Locations
Start Date
2008-02
Trial ID
NCT00462384
Treatments Being Tested
This is a multi-center, randomized, double blind, placebo-controlled study ...
Status
Unknown
Location
The First Affiliated Hospital of Guangzhou Medical University
Start Date
2022-07-19
Trial ID
NCT06642961
Treatments Being Tested
The main objective of this study is to evaluate the safety and tolerability...
Status
Terminated
Location
Institute of Healthcare Assessment, Inc
Start Date
2008-03
Trial ID
NCT00590720
Treatments Being Tested
To assess the clinical efficacy and safety of certolizumab pegol as add-on ...
Status
Completed
Location
Multiple Locations
Start Date
2008-06
Trial ID
NCT00674362
Treatments Being Tested